Plasticity of empty major histocompatibility complex class I molecules determines peptide-selector function

Molecular Immunology

Volumn 68, Issue 2, 2015, Pages 98-101

  Van Hateren, Andy ^a,b   Bailey, Alistair ^a,b   Werner, Jörn M ^a   Elliott, Tim ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

MHC class I; Peptide editing; Peptide selection; Protein plasticity; Tapasin

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; TAPASIN; CARRIER PROTEIN; HLA ANTIGEN CLASS 1; PROTEIN BINDING;

ALLELE; AMINO ACID SEQUENCE; CYTOTOXIC T LYMPHOCYTE; PLASTICITY; PRIORITY JOURNAL; PROTEIN CONFORMATION; REVIEW; ANIMAL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CHEMISTRY; CYTOLOGY; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR DYNAMICS; PROTEIN FOLDING; PROTEIN TERTIARY STRUCTURE;

ALLELES; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR DYNAMICS SIMULATION; PEPTIDES; POLYMORPHISM, GENETIC; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84955658694     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2015.03.010     Document Type: Review

References (22)

1. Bouvier M., Wiley D.C. Structural characterization of a soluble and partially folded class I major histocompatibility heavy chain/beta 2 m heterodimer. Nat. Struct. Biol. 1998, 5:377-384.
2. Chen M., Bouvier M. Analysis of interactions in a tapasin/class I complex provides a mechanism for peptide selection. EMBO J. 2007, 26:1681-1690.
3. Dong G., Wearsch P.A., Peaper D.R., Cresswell P., Reinisch K.M. Insights into MHC class I peptide loading from the structure of the tapasin-ERp57 thiol oxidoreductase heterodimer. Immunity 2009, 30:21-32.
4. Ford S., Antoniou A., Butcher G.W., Powis S.J. Competition for access to the rat major histocompatibility complex class I peptide-loading complex reveals optimization of peptide cargo in the absence of transporter associated with antigen processing (TAP) association. J. Biol. Chem. 2004, 279:16077-16082.
5. Garbi N., Tan P., Diehl A.D., Chambers B.J., Ljunggren H.G., Momburg F., Hammerling G.J. Impaired immune responses and altered peptide repertoire in tapasin-deficient mice. Nat. Immunol. 2000, 1:234-238.
6. Garstka M.A., Fritzsche S., Lenart I., Hein Z., Jankevicius G., Boyle L.H., Elliott T., Trowsdale J., Antoniou A.N., Zacharias M., Springer S. Tapasin dependence of major histocompatibility complex class I molecules correlates with their conformational flexibility. FASEB J. 2011, 25:3989-3998.
7. Grandea A.G., Golovina T.N., Hamilton S.E., Sriram V., Spies T., Brutkiewicz R.R., Harty J.T., Eisenlohr L.C., Van Kaer L. Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice. Immunity 2000, 13:213-222.
8. Greenwood R., Shimizu Y., Sekhon G.S., DeMars R. Novel allele-specific, post-translational reduction in HLA class I surface expression in a mutant human B cell line. J. Immunol. 1994, 153:5525-5536.
9. Howarth M., Williams A., Tolstrup A.B., Elliott T. Tapasin enhances MHC class I peptide presentation according to peptide half-life. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:11737-11742.
10. Lehner P.J., Surman M.J., Cresswell P. Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line.220. Immunity 1998, 8:221-231.
11. Lewis J.W., Elliott T. Evidence for successive peptide binding and quality control stages during MHC class I assembly. Curr. Biol. 1998, 8:717-720.
12. Ostermeir K., Springer S., Zacharias M. Coupling between side chain interactions and binding pocket flexibility in HLA-B*44:02 molecules investigated by molecular dynamics simulations. Mol. Immunol. 2015, 63:312-319.
13. Peh C.A., Burrows S.R., Barnden M., Khanna R., Cresswell P., Moss D.J., McCluskey J. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 1998, 8:531-542.
14. Rizvi S.M., Salam N., Geng J., Qi Y., Bream J.H., Duggal P., Hussain S.K., Martinson J., Wolinsky S.M., Carrington M., Raghavan M. Distinct assembly profiles of HLA-B molecules. J. Immunol. 2014, 192:4967-4976.
15. Sadasivan B., Lehner P.J., Ortmann B., Spies T., Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 1996, 5:103-114.
16. Saini S.K., Abualrous E.T., Tigan A.S., Covella K., Wellbrock U., Springer S. Not all empty MHC class I molecules are molten globules: tryptophan fluorescence reveals a two-step mechanism of thermal denaturation. Mol. Immunol. 2013, 54:386-396.
17. Sieker F., Springer S., Zacharias M. Comparative molecular dynamics analysis of tapasin-dependent and -independent MHC class I alleles. Protein Sci. 2007, 16:299-308.
18. van Hateren A., James E., Bailey A., Phillips A., Dalchau N., Elliott T. The cell biology of major histocompatibility complex class I assembly: towards a molecular understanding. Tissue Antigens 2010, 76:259-275.
19. van Hateren A., Carter R., Bailey A., Kontouli N., Williams A.P., Kaufman J., Elliott T. A mechanistic basis for the co-evolution of chicken tapasin and major histocompatibility complex class I (MHC I) proteins. J. Biol. Chem. 2013, 288:32797-32808.
20. Wearsch P.A., Cresswell P. Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer. Nat. Immunol. 2007, 8:873-881.
21. Williams A.P., Peh C.A., Purcell A.W., McCluskey J., Elliott T. Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity 2002, 16:509-520.
22. Zernich D., Purcell A.W., Macdonald W.A., Kjer-Nielsen L., Ely L.K., Laham N., Crockford T., Mifsud N.A., Bharadwaj M., Chang L., Tait B.D., Holdsworth R., Brooks A.G., Bottomley S.P., Beddoe T., Peh C.A., Rossjohn J., McCluskey J. Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. J. Exp. Med. 2004, 200:13-24.